loqmane seridi
loqmane seridi
Scientist, Johnson & Johnson Pharmaceutical Research and Development
Verified email at
Cited by
Cited by
Specificity and transcriptional activity of microbiota associated with low and high microbial abundance sponges from the Red Sea
L Moitinho‐Silva, K Bayer, CV Cannistraci, EC Giles, T Ryu, L Seridi, ...
Molecular ecology 23 (6), 1348-1363, 2014
Molecular processes of transgenerational acclimation to a warming ocean
HD Veilleux, T Ryu, JM Donelson, L Van Herwerden, L Seridi, Y Ghosheh, ...
Nature Climate Change 5 (12), 1074-1078, 2015
Hologenome analysis of two marine sponges with different microbiomes
T Ryu, L Seridi, L Moitinho-Silva, M Oates, YJ Liew, C Mavromatis, ...
BMC genomics 17, 1-11, 2016
Revealing microbial functional activities in the Red Sea sponge Stylissa carteri by metatranscriptomics
L Moitinho‐Silva, L Seridi, T Ryu, CR Voolstra, T Ravasi, U Hentschel
Environmental Microbiology 16 (12), 3683-3698, 2014
Characterization of piRNAs across postnatal development in mouse brain
Y Ghosheh, L Seridi, T Ryu, H Takahashi, V Orlando, P Carninci, T Ravasi
Scientific reports 6 (1), 25039, 2016
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus
RF van Vollenhoven, KC Kalunian, T Dörner, BH Hahn, Y Tanaka, ...
Annals of the rheumatic diseases 81 (11), 1556-1563, 2022
The evolution of ultraconserved elements with different phylogenetic origins
T Ryu, L Seridi, T Ravasi
BMC evolutionary biology 12, 1-11, 2012
Nuclear AGO1 regulates gene expression by affecting chromatin architecture in human cells
M Shuaib, KM Parsi, M Thimma, SA Adroub, H Kawaji, L Seridi, ...
Cell systems 9 (5), 446-458. e6, 2019
Transcriptome analysis elucidates key developmental components of bryozoan lophophore development
YH Wong, T Ryu, L Seridi, Y Ghosheh, S Bougouffa, PY Qian, T Ravasi
Scientific reports 4 (1), 6534, 2014
Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome
L Seridi, GC Leo, GL Dohm, WJ Pories, J Lenhard
PLoS One 13 (5), e0198156, 2018
Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus
M Cesaroni, L Seridi, MJ Loza, J Schreiter, K Sweet, C Franks, K Ma, ...
Arthritis & Rheumatology 73 (3), 472-477, 2021
Transcriptome and proteome dynamics in larvae of the barnacle Balanus Amphitrite from the Red Sea
KH Chandramouli, S Al-Aqeel, T Ryu, H Zhang, L Seridi, Y Ghosheh, ...
BMC genomics 16, 1-17, 2015
Dynamic epigenetic control of highly conserved noncoding elements
L Seridi, T Ryu, T Ravasi
PLoS One 9 (10), e109326, 2014
First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial
J Jordan, J Benson, WW Chatham, RA Furie, W Stohl, JCC Wei, ...
The Lancet Rheumatology 2 (10), e613-e622, 2020
Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition
L Seridi, M Cesaroni, A Orillion, J Schreiter, M Chevrier, S Marciniak, ...
Lupus 30 (5), 795-806, 2021
Response to ustekinumab treatment in patients with systemic lupus erythematosus is linked to suppression of serum interferon gamma levels
M Cesaroni, L Seridi, MJ Loza, J Schreiter, K Sweet, C Franks
Arthritis Rheumatol 73 (3), 10.1002, 2020
OP0278 biomarker profiling reveals novel mechanistic insights into ustekinumab therapeutic responses in systemic lupus erythematosus
M Cesaroni, L Seridi, J Jordan, K Sweet, MA Keying, C Franks, J Schreiter, ...
Annals of the Rheumatic Diseases 78 (Suppl 2), 220-221, 2019
AGO1 in association with NEAT1 lncRNA contributes to nuclear and 3D chromatin architecture in human cells
M Shuaib, KM Parsi, H Kawaji, M Thimma, SA Adroub, A Fort, Y Ghosheh, ...
bioRxiv, 525527, 2019
OP0161 association of baseline cytotoxic gene expression with ustekinumab response in systemic lupus erythematosus
L Seridi, M Cesaroni, MJ Loza, J Schreiter, K Sweet, Y Orlovsky, ...
Annals of the Rheumatic Diseases 79 (Suppl 1), 101-102, 2020
251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus
J Jordan, K Sweet, M Cesaroni, K Ma, C Franks, L Seridi, J Schreiter, ...
Lupus Science & Medicine 6 (Suppl 1), 2019
The system can't perform the operation now. Try again later.
Articles 1–20